Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Hepatitis

  Free Subscription


Articles published in Am J Gastroenterol

Retrieve available abstracts of 51 articles:
HTML format
Text format



Single Articles


    November 2017
  1. KWO PY, Shiffman ML, Bernstein DE
    The Cochrane Review Conclusion for Hepatitis C DAA Therapies is Wrong.
    Am J Gastroenterol. 2017 Nov 14. doi: 10.1038/ajg.2017.
    PubMed     Text format    


  2. SOLLIMA S, Milazzo L, Antinori S, Galli M, et al
    Direct-Acting Antivirals and Mixed Cryoglobulinemia Vasculitis: Long-Term Outcome of Patients Achieving HCV Eradication.
    Am J Gastroenterol. 2017;112:1753-1754.
    PubMed     Text format    


  3. LIU X, Shen JJ, Lee JL, Yoo JW, et al
    Cost-Effective but Unaffordable and Unequal Hepatitis C Treatment in the US.
    Am J Gastroenterol. 2017;112:1749.
    PubMed     Text format    


    October 2017
  4. WU T, Kwok RM, Tran TT
    Isolated anti-HBc: The Relevance of Hepatitis B Core Antibody-A Review of New Issues.
    Am J Gastroenterol. 2017 Oct 31. doi: 10.1038/ajg.2017.
    PubMed     Text format     Abstract available


  5. KECK C, Shetty A, Mischen B, Willner I, et al
    Hepatic Splenosis Masquerading as Hepatocellular Carcinoma in a Chronic Hepatitis C Patient.
    Am J Gastroenterol. 2017;112:1493.
    PubMed     Text format    


    September 2017
  6. CHON YE, Park JY, Myoung SM, Jung KS, et al
    Corrigendum: Improvement of Liver Fibrosis after Long-Term Antiviral Therapy Assessed by Fibroscan in Chronic Hepatitis B Patients With Advanced Fibrosis.
    Am J Gastroenterol. 2017 Sep 12. doi: 10.1038/ajg.2017.
    PubMed     Text format    


  7. HUANG R, Yan X, Liu Y, Zhang Z, et al
    Can Transient Elastography Predict Fibrosis Regression in Patients with Chronic Hepatitis B During Long-Term Antiviral Therapy?
    Am J Gastroenterol. 2017;112:1477-1478.
    PubMed     Text format    


  8. KOFF RS
    Editorial: Direct Antiviral Agents Eliminate the Age Barrier to Treatment of Chronic Hepatitis C.
    Am J Gastroenterol. 2017;112:1410-1411.
    PubMed     Text format     Abstract available


  9. LENS S, Fernandez I, Rodriguez-Tajes S, Hontangas V, et al
    Interferon-Free Therapy in Elderly Patients With Advanced Liver Disease.
    Am J Gastroenterol. 2017;112:1400-1409.
    PubMed     Text format     Abstract available


    August 2017
  10. TSENG TC, Liu CJ, Su TH, Yang WT, et al
    Fibrosis-4 Index Helps Identify HBV Carriers With the Lowest Risk of Hepatocellular Carcinoma.
    Am J Gastroenterol. 2017 Aug 29. doi: 10.1038/ajg.2017.
    PubMed     Text format     Abstract available


  11. MARTIN P, Fabrizi F
    Editorial: Benefit of Direct-Acting Antiviral Therapy For Cryoglobulinemia due to Hepatitis C Infection.
    Am J Gastroenterol. 2017;112:1309-1310.
    PubMed     Text format     Abstract available


  12. EMERY JS, Kuczynski M, La D, Almarzooqi S, et al
    Efficacy and Safety of Direct Acting Antivirals for the Treatment of Mixed Cryoglobulinemia.
    Am J Gastroenterol. 2017;112:1298-1308.
    PubMed     Text format     Abstract available


    July 2017
  13. PELLICANO R
    Is Viral Hepatitis Decreasing in the United States?
    Am J Gastroenterol. 2017;112:1170.
    PubMed     Text format    


    June 2017
  14. TOYODA H, Kumada T, Tada T
    Hepatitis B Core-Related Antigen: A Possible Indicator for the Termination of Prophylactic Nucleos(t)ide Analogue Therapy in Patients After Immunosuppressive Therapy.
    Am J Gastroenterol. 2017;112:969-970.
    PubMed     Text format    


    April 2017
  15. LEE MH, Hsiao TI, Subramaniam SR, Le AK, et al
    HCV Genotype 6 Increased the Risk for Hepatocellular Carcinoma Among Asian Patients With Liver Cirrhosis.
    Am J Gastroenterol. 2017 Apr 25. doi: 10.1038/ajg.2017.
    PubMed     Text format     Abstract available


  16. OOKA K, Connolly JJ, Lim JK
    Medicaid Reimbursement for Oral Direct Antiviral Agents for the Treatment of Chronic Hepatitis C.
    Am J Gastroenterol. 2017 Apr 4. doi: 10.1038/ajg.2017.
    PubMed     Text format    


  17. CHON YE, Park JY, Myoung SM, Jung KS, et al
    Improvement of Liver Fibrosis after Long-Term Antiviral Therapy Assessed by Fibroscan in Chronic Hepatitis B Patients With Advanced Fibrosis.
    Am J Gastroenterol. 2017 Apr 4. doi: 10.1038/ajg.2017.
    PubMed     Text format     Abstract available


  18. GARCIA-SAENZ-DE-SICILIA M, Duvoor C, Altamirano J, Chavez-Araujo R, et al
    Corrigendum: A Day-4 Lille Model Predicts Response to Corticosteroids and Mortality in Severe Alcoholic Hepatitis.
    Am J Gastroenterol. 2017;112:666.
    PubMed     Text format    


    February 2017
  19. KARIMI-SARI H, Tajik M, Bayatpoor ME, Alavian SM, et al
    Increasing the Awareness of the General Population: An Important Step in Elimination Programs of Viral Hepatitis.
    Am J Gastroenterol. 2017;112:393-395.
    PubMed     Text format    


  20. HUANG YW, Hsieh AC, Yang SS
    Safety of Statins in Chronic Hepatitis B Patients.
    Am J Gastroenterol. 2017;112:385-386.
    PubMed     Text format    


  21. TAKYAR V, Kleiner DE, Koh C
    A Wolf in Sheep's Clothing in the Era of Non-Invasive Staging: Non-Hodgkin's Lymphoma Masquerading as Serologic HCV Cirrhosis.
    Am J Gastroenterol. 2017;112:398-399.
    PubMed     Text format    


  22. LO GH
    Did Statins Really Reduce the Risk of Cirrhosis and Decompensation in Chronic Hepatitis B Patients?
    Am J Gastroenterol. 2017;112:386-387.
    PubMed     Text format    


  23. YANG JD, Mohamed HA, Cvinar JL, Gores GJ, et al
    Corrigendum: Diabetes Mellitus Heightens the Risk of Hepatocellular Carcinoma Except in Patients With Hepatitis C Cirrhosis.
    Am J Gastroenterol. 2017;112:402.
    PubMed     Text format    


    January 2017
  24. FARRAYE FA, Melmed GY, Lichtenstein GR, Kane SV, et al
    ACG Clinical Guideline: Preventive Care in Inflammatory Bowel Disease.
    Am J Gastroenterol. 2017 Jan 10. doi: 10.1038/ajg.2016.
    PubMed     Text format     Abstract available


  25. KWO PY, Cohen SM, Lim JK
    ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries.
    Am J Gastroenterol. 2017;112:18-35.
    PubMed     Text format     Abstract available


    December 2016
  26. GARCIA-SAENZ-DE-SICILIA M, Duvoor C, Altamirano J, Chavez-Araujo R, et al
    A Day-4 Lille Model Predicts Response to Corticosteroids and Mortality in Severe Alcoholic Hepatitis.
    Am J Gastroenterol. 2016 Dec 6. doi: 10.1038/ajg.2016.
    PubMed     Text format     Abstract available


  27. PILLAI AA, Anania FA, Pearlman BL
    Caution: Reactivation of Hepatitis B during Hepatitis C Treatment with Direct-Acting Antiviral Therapy.
    Am J Gastroenterol. 2016;111:1854-1856.
    PubMed     Text format    


  28. SETO WK, Wong DH, Chan TY, Hwang YY, et al
    Erratum: Association of Hepatitis B Core-Related Antigen With Hepatitis B Virus Reactivation in Occult Viral Carriers Undergoing High-Risk Immunosuppressive Therapy.
    Am J Gastroenterol. 2016;111:1858.
    PubMed     Text format    


    November 2016
  29. HUANG YW, Hsieh AC, Yang SS
    Statins and the Risk of Cirrhosis and Its Decompensation in Chronic Hepatitis B Patients.
    Am J Gastroenterol. 2016;111:1655-1656.
    PubMed     Text format    


  30. HU YW
    Statins and the Risk of Cirrhosis in Chronic Hepatitis B Patients.
    Am J Gastroenterol. 2016;111:1655.
    PubMed     Text format    


    October 2016
  31. CHO HJ, Kim B, Lee JD, Kang DR, et al
    Development of Risk Prediction Model for Hepatocellular Carcinoma Progression of Indeterminate Nodules in Hepatitis B Virus-Related Cirrhotic Liver.
    Am J Gastroenterol. 2016 Oct 25. doi: 10.1038/ajg.2016.
    PubMed     Text format     Abstract available


    September 2016
  32. SETO WK, Wong DH, Chan TY, Hwang YY, et al
    Association of Hepatitis B Core-Related Antigen With Hepatitis B Virus Reactivation in Occult Viral Carriers Undergoing High-Risk Immunosuppressive Therapy.
    Am J Gastroenterol. 2016 Sep 20. doi: 10.1038/ajg.2016.
    PubMed     Text format     Abstract available


    August 2016
  33. YANG JD, Mohamed HA, Cvinar JL, Gores GJ, et al
    Diabetes Mellitus Heightens the Risk of Hepatocellular Carcinoma Except in Patients With Hepatitis C Cirrhosis.
    Am J Gastroenterol. 2016 Aug 16. doi: 10.1038/ajg.2016.
    PubMed     Text format     Abstract available


    July 2016
  34. CHANG CY, Aziz N, Poongkunran M, Javaid A, et al
    Serum Alanine Aminotransferase and Hepatitis B DNA Flares in Pregnant and Postpartum Women with Chronic Hepatitis B.
    Am J Gastroenterol. 2016 Jul 26. doi: 10.1038/ajg.2016.
    PubMed     Text format     Abstract available


  35. SHIFFMAN ML, Rustgi V, Bennett M, Forns X, et al
    Corrigendum: Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir Plus Dasabuvir With or Without Ribavirin in HCV-Infected Patients Taking Concomitant Acid-Reducing Agents.
    Am J Gastroenterol. 2016;111:1077.
    PubMed     Text format    


    June 2016
  36. AHN J, Lim JK, Lee HM, Lok AS, et al
    Lower Observed Hepatocellular Carcinoma Incidence in Chronic Hepatitis B Patients Treated With Entecavir: Results of the ENUMERATE Study.
    Am J Gastroenterol. 2016 Jun 21. doi: 10.1038/ajg.2016.
    PubMed     Text format     Abstract available


  37. SCHITZ A, Moser S, Marchart K, Haltmayer H, et al
    Direct Observed Therapy of Chronic Hepatitis C With Interferon-Free All-Oral Regimens at a Low-Threshold Drug Treatment Facility-a New Concept for Treatment of Patients With Borderline Compliance Receiving Opioid Substitution Therapy.
    Am J Gastroenterol. 2016;111:903-5.
    PubMed     Text format    


    May 2016
  38. HUANG YW, Lee CL, Yang SS, Fu SC, et al
    Statins Reduce the Risk of Cirrhosis and Its Decompensation in Chronic Hepatitis B Patients: A Nationwide Cohort Study.
    Am J Gastroenterol. 2016 May 10. doi: 10.1038/ajg.2016.
    PubMed     Text format     Abstract available


  39. STERN R, Hametner S, Ramona AZ, Moser S, et al
    Interferon/Ribavirin-Free Antiviral Treatment in Septuagenarians and Octogenarians With Chronic Hepatitis C.
    Am J Gastroenterol. 2016;111:744-5.
    PubMed     Text format    


    April 2016
  40. SHIFFMAN ML, Rustgi V, Bennett M, Forns X, et al
    Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir Plus Dasabuvir With or Without Ribavirin in HCV-Infected Patients Taking Concomitant Acid-Reducing Agents.
    Am J Gastroenterol. 2016 Apr 5. doi: 10.1038/ajg.2016.
    PubMed     Text format     Abstract available


  41. WANG CC, Tseng KC, Hsieh TY, Tseng TC, et al
    Assessing the Durability of Entecavir-Treated Hepatitis B Using Quantitative HBsAg.
    Am J Gastroenterol. 2016 Apr 5. doi: 10.1038/ajg.2016.
    PubMed     Text format     Abstract available


  42. SENATORE FJ, McDonald K
    Pitfalls of Treating Alcoholic Hepatitis: Recognizing Hemolytic Anemia in Zieve's Syndrome.
    Am J Gastroenterol. 2016;111:577-9.
    PubMed     Text format    


    March 2016
  43. YOUNOSSI ZM, Stepanova M, Henry L, Nader F, et al
    An In-Depth Analysis of Patient-Reported Outcomes in Patients With Chronic Hepatitis C Treated With Different Anti-Viral Regimens.
    Am J Gastroenterol. 2016 Mar 29. doi: 10.1038/ajg.2016.
    PubMed     Text format     Abstract available


  44. SHI Y, Xia F, Li QJ, Li JH, et al
    Magnetic Resonance Elastography for the Evaluation of Liver Fibrosis in Chronic Hepatitis B and C by Using Both Gradient-Recalled Echo and Spin-Echo Echo Planar Imaging: A Prospective Study.
    Am J Gastroenterol. 2016 Mar 15. doi: 10.1038/ajg.2016.
    PubMed     Text format     Abstract available


  45. LIU KL, Shih IL, Huang YC, Chen CH, et al
    Image of the Month: Abdominoscrotal Hydrocele.
    Am J Gastroenterol. 2016;111:312.
    PubMed     Text format    


    February 2016
  46. PILLAI AA, Wedd J, Norvell JP, Parekh S, et al
    Simeprevir and Sofosbuvir (SMV-SOF) for 12 Weeks for the Treatment of Chronic Hepatitis C Genotype 1 Infection: A Real World (Transplant) Hepatology Practice Experience.
    Am J Gastroenterol. 2016 Feb 2. doi: 10.1038/ajg.2015.
    PubMed     Text format     Abstract available


  47. COLLYER E, Kay M
    Response to Fontana et al.
    Am J Gastroenterol. 2016;111:297.
    PubMed     Text format    


  48. FONTANA RJ
    Response to Collyer et al.
    Am J Gastroenterol. 2016;111:297-8.
    PubMed     Text format    


  49. TRAN TT, Ahn J, Reau NS
    ACG Clinical Guideline: Liver Disease and Pregnancy.
    Am J Gastroenterol. 2016;111:176-94.
    PubMed     Text format     Abstract available


    November 2015
  50. YANG JD, Gyedu A, Afihene MY, Duduyemi BM, et al
    Hepatocellular Carcinoma Occurs at an Earlier Age in Africans, Particularly in Association With Chronic Hepatitis B.
    Am J Gastroenterol. 2015;110:1629-31.
    PubMed     Text format    


    September 2015
  51. FONTANA RJ, Hayashi PH, Barnhart H, Kleiner DE, et al
    Persistent Liver Biochemistry Abnormalities Are More Common in Older Patients and those With Cholestatic Drug Induced Liver Injury.
    Am J Gastroenterol. 2015 Sep 8. doi: 10.1038/ajg.2015.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: